levetiracetam
Generic: levetiracetam
Labeler: sciegen pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam
Labeler
sciegen pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
levetiracetam 250 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50228-470
Product ID
50228-470_1ea253c3-3086-2b26-e063-6394a90a312e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215069
Listing Expiration
2026-12-31
Marketing Start
2022-05-27
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50228470
Hyphenated Format
50228-470
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA215069 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 500 TABLET, FILM COATED in 1 BOTTLE (50228-470-05)
- 1000 TABLET, FILM COATED in 1 BOTTLE (50228-470-10)
- 120 TABLET, FILM COATED in 1 BOTTLE (50228-470-12)
- 30 TABLET, FILM COATED in 1 BOTTLE (50228-470-30)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1ea253c3-3086-2b26-e063-6394a90a312e", "openfda": {"nui": ["N0000008486"], "upc": ["0350228472050", "0350228470056", "0350228472128", "0350228471121", "0350228473606", "0350228471053", "0350228470124"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290", "387003"], "spl_set_id": ["1d71212b-ac97-4a61-8192-8e8303540019"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["ScieGen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (50228-470-05)", "package_ndc": "50228-470-05", "marketing_start_date": "20220527"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (50228-470-10)", "package_ndc": "50228-470-10", "marketing_start_date": "20220527"}, {"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (50228-470-12)", "package_ndc": "50228-470-12", "marketing_start_date": "20220527"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50228-470-30)", "package_ndc": "50228-470-30", "marketing_start_date": "20220527"}], "brand_name": "Levetiracetam", "product_id": "50228-470_1ea253c3-3086-2b26-e063-6394a90a312e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50228-470", "generic_name": "Levetiracetam", "labeler_name": "ScieGen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "250 mg/1"}], "application_number": "ANDA215069", "marketing_category": "ANDA", "marketing_start_date": "20220527", "listing_expiration_date": "20261231"}